Who owns ArriVent BioPharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AVBP from SEC Form 13F filings across 153 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 153 institutions disclosed 50.5M shares of ArriVent BioPharma, Inc. worth $1.53B — about 101.9% of shares outstanding; the largest disclosed holder is MONTANOVA CAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
153
13F holders
$1.53B
value, 2026 filers
101.9%
of shares outstanding (50.5M sh)
18
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of AVBP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 4.9M | $149.1M | 3.5% | 9.9% | +9.1% |
| 2 | INFINITUM ASSET MANAGEMENT, LLC | 4.5M | $137.0M | 11.9% | 9.1% | +1.9% |
| 3 | HHLR ADVISORS, LTD. | 3.9M | $119.0M | 7.7% | 7.9% | 0.0% |
| 4 | BlackRock, Inc. | 3.4M | $103.2M | 0.0% | 6.9% | +4.8% |
| 5 | ORBIMED ADVISORS LLC | 3.0M | $91.7M | 1.7% | 6.1% | 0.0% |
| 6 | FMR LLC | 3.0M | $89.8M | 0.0% | 6% | +6.8% |
| 7 | Octagon Capital Advisors LP | 2.1M | $64.8M | 8.6% | 4.3% | +8.6% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $60.9M | 0.0% | 4.1% | +13.3% |
| 9 | Vivo Capital, LLC | 1.8M | $54.1M | 6.0% | 3.6% | +6.2% |
| 10 | STATE STREET CORP | 1.8M | $53.4M | 0.0% | 3.6% | +4.1% |
| 11 | Sofinnova Investments, Inc. | 1.7M | $51.4M | 2.2% | 3.4% | 0.0% |
| 12 | General Catalyst Group Management, LLC | 1.5M | $45.3M | 9.5% | 3% | 0.0% |
| 13 | Logos Global Management LP | 1.4M | $40.9M | 2.2% | 2.7% | +35.0% |
| 14 | NOVO HOLDINGS A/S | 1.2M | $35.6M | 2.4% | 2.4% | -21.7% |
| 15 | GOLDMAN SACHS GROUP INC | 1.1M | $33.5M | 0.0% | 2.2% | +29.7% |
| 16 | BANK OF AMERICA CORP /DE/ | 1.1M | $32.4M | 0.0% | 2.2% | +512.4% |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $32.0M | 0.0% | 2.1% | +8.5% |
| 18 | D. E. Shaw & Co., Inc. | 908,475 | $27.5M | 0.0% | 1.8% | +4.2% |
| 19 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 685,526 | $20.8M | 0.0% | 1.4% | new |
| 20 | HSG Holding Ltd | 663,308 | $20.1M | 1.6% | 1.3% | 0.0% |
| 21 | UBS Group AG | 541,521 | $16.4M | 0.0% | 1.1% | +23.5% |
| 22 | MILLENNIUM MANAGEMENT LLC | 508,511 | $15.4M | 0.0% | 1% | +15.9% |
| 23 | Balyasny Asset Management L.P. | 503,383 | $15.2M | 0.0% | 1% | +27.3% |
| 24 | Point72 Asset Management, L.P. | 493,205 | $14.9M | 0.0% | 1% | -13.0% |
| 25 | Foresite Capital Management VI LLC | 490,341 | $14.8M | 2.6% | 1% | +62.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.